// App-Quantinova.ai

AB0400 : PATIENT-REPORTED OUTCOME MEASURES IN SWEDISH PATIENTS WITH RECENT-ONSET SLE VERSUS RA IN THE FIRST 60 MONTHS AFTER DIAGNOSIS

Researchers

Presenter

  • M. Bjork

Principal Investigators

  • I. Thyberg

  • A. Kastbom

  • R. Heijke

  • L. Mcdonald

  • E. Alemao

  • C. Sjowall

Medical Centers

  • Linkoping University, Linkoping, Sweden

  • Bristol-Myers Squibb, Uxbridge, United Kingdom

  • Bristol-Myers Squibb Company, Lawrencville, NJ, United States of America

Locations

  • Sweden

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved